Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
20.27
+0.50 (2.53%)
At close: Mar 6, 2026

Nanjing Vazyme Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,0627,9638,81112,80821,25742,401
Market Cap Growth
-2.92%-9.63%-31.21%-39.74%-49.87%-
Enterprise Value
6,1996,1006,99510,67018,87741,383
Last Close Price
20.2720.0222.0231.6150.47100.29
PE Ratio
----35.7762.51
Forward PE
64.6974.6243.6948.0323.2157.10
PS Ratio
5.855.786.409.965.9622.69
PB Ratio
2.102.072.233.184.6110.27
P/TBV Ratio
2.222.202.373.374.8010.32
P/FCF Ratio
-----119.49
P/OCF Ratio
---83.7228.9168.74
EV/Sales Ratio
4.504.435.088.305.2922.15
EV/EBITDA Ratio
112.79110.98--20.6654.37
EV/EBIT Ratio
----22.2056.70
EV/FCF Ratio
-----116.63
Debt / Equity Ratio
0.220.220.190.320.100.02
Debt / EBITDA Ratio
15.6715.6729.87-0.470.12
Debt / FCF Ratio
-----0.26
Net Debt / Equity Ratio
-0.48-0.48-0.48-0.54-0.61-0.81
Net Debt / EBITDA Ratio
-33.84-33.84109.4712.62-3.07-4.42
Net Debt / FCF Ratio
--22.5227.4512.32-9.48
Asset Turnover
--0.260.220.670.60
Inventory Turnover
--1.241.454.592.08
Quick Ratio
--3.502.533.569.76
Current Ratio
--3.952.783.9610.46
Return on Equity (ROE)
-0.44%-0.44%-0.49%-1.69%13.58%24.85%
Return on Assets (ROA)
---1.31%-2.89%10.02%14.67%
Return on Invested Capital (ROIC)
-2.04%-2.01%-5.83%-14.91%64.41%119.81%
Return on Capital Employed (ROCE)
---2.70%-6.40%17.50%17.30%
Earnings Yield
-0.21%-0.21%-0.21%-0.55%2.80%1.60%
FCF Yield
---0.96%-0.62%-1.07%0.84%
Dividend Yield
1.48%-0.82%0.32%2.48%0.30%
Payout Ratio
----22.25%0.66%
Buyback Yield / Dilution
-17.24%-17.24%8.20%1.16%-9.95%-1.97%
Total Shareholder Return
-15.72%-17.24%9.02%1.47%-7.48%-1.67%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.